Advertisement

 

 

In-hospital ischaemic stroke treated with intravenous thrombolysis or mechanical thrombectomy.

In-hospital ischaemic stroke treated with intravenous thrombolysis or mechanical thrombectomy.
Author Information (click to view)

Caparros F, Ferrigno M, Decourcelle A, Hochart A, Moulin S, Dequatre N, Bodenant M, Hénon H, Cordonnier C, Leys D,


Caparros F, Ferrigno M, Decourcelle A, Hochart A, Moulin S, Dequatre N, Bodenant M, Hénon H, Cordonnier C, Leys D, (click to view)

Caparros F, Ferrigno M, Decourcelle A, Hochart A, Moulin S, Dequatre N, Bodenant M, Hénon H, Cordonnier C, Leys D,

Advertisement

Journal of neurology 2017 07 15() doi 10.1007/s00415-017-8570-4
Abstract

Patients with in-hospital strokes (IHS) may be eligible for recanalization therapies. The objective of this study is to compare outcomes in patients with IHS and community-onset strokes (COS) treated by recanalization therapy. We analysed data prospectively collected in consecutive patients treated by thrombolysis, thrombectomy, or both for cerebral ischemia at the Lille University Hospital. We compared four outcomes measures at 3 months in patients with IHS and COS: (1) modified Rankin scale (mRS) 0-1, (2) mRS 0-2, (3) death, and (4) symptomatic intracranial haemorrhage (ECASS 2 definition). Of 1209 patients, 64 (5.3%) had IHS, with an increasing proportion over time (p = 0.001). Their median onset-to-needle time was 128 min vs. 145 in COS (p < 0.001). They were more likely to have had a recent TIA [odds ratio (OR) 30.1; 95% confidence interval (CI) 11.5-78.7], to have been treated by vitamin K antagonist before (OR 4.2; 95% CI 1.4-12.0) and to undergo mechanical thrombectomy (45 vs. 10%, p < 0.001). They were less likely to have a pre-stroke mRS 0-1 (OR 0.22; 95% CI 0.09-0.50). After adjustment, IHS was not associated with any of the four outcome measures. Patients with IHS are treated 17 min earlier than patients with COS, but, taking into account that they were already in the hospital, delays are still too long. Their outcome does not differ from that of patients with COS, suggesting room for improvement if delays can be reduced. IHS being frequent, pre-specified pathways should be organised.

Submit a Comment

Your email address will not be published. Required fields are marked *

5 × 3 =

[ HIDE/SHOW ]